Loading…

Enantiomer-Specific In Vitro Biotransformation of Select Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss)

ABSTRACT The occurrence of pharmaceuticals in the environment represents a challenge of emerging concern. Many pharmaceuticals are chiral compounds; however, few studies have examined the relative toxicity of pharmaceutical enantiomers to wildlife. Further, our understanding of stereospecific pharma...

Full description

Saved in:
Bibliographic Details
Published in:Chirality (New York, N.Y.) N.Y.), 2013-11, Vol.25 (11), p.763-767
Main Authors: Connors, Kristin A., Du, Bowen, Fitzsimmons, Patrick N., Chambliss, C. Kevin, Nichols, John W., Brooks, Bryan W.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4611-a75734d094897d7c16cd3753960628a4e58ede82063b4bffea80b5a0b57df8433
cites cdi_FETCH-LOGICAL-c4611-a75734d094897d7c16cd3753960628a4e58ede82063b4bffea80b5a0b57df8433
container_end_page 767
container_issue 11
container_start_page 763
container_title Chirality (New York, N.Y.)
container_volume 25
creator Connors, Kristin A.
Du, Bowen
Fitzsimmons, Patrick N.
Chambliss, C. Kevin
Nichols, John W.
Brooks, Bryan W.
description ABSTRACT The occurrence of pharmaceuticals in the environment represents a challenge of emerging concern. Many pharmaceuticals are chiral compounds; however, few studies have examined the relative toxicity of pharmaceutical enantiomers to wildlife. Further, our understanding of stereospecific pharmacokinetics remains largely informed by research on humans and a few well‐studied laboratory test animals, and not by studies conducted with environmentally relevant species, including fish. The objective of this study was to investigate whether rainbow trout display stereospecific in vitro metabolism of three common chiral pharmaceuticals. Metabolism by trout liver S9 fractions was evaluated using a substrate depletion approach, which provides an estimate of intrinsic hepatic clearance (CLIN VITRO,INT). No biotransformation was observed for rac‐, R‐, or S‐fluoxetine. Ibuprofen, including both enantiomers and the racemic mixture, appeared to undergo slow metabolism, but the resulting substrate depletion curves did not differ significantly from those of inactive controls. Contrary to relative clearance rates in humans, S(−)‐propranolol was more rapidly cleared than the R(+)‐ enantiomer. This work demonstrates that relative clearance rates and the effects of racemic mixtures in trout could not have been predicted based on human data. Additional research describing species differences and exploring tools for species extrapolation in biomedical and environmental studies is needed. Chirality 25:763–767, 2013, © 2013 Wiley Periodicals, Inc.
doi_str_mv 10.1002/chir.22211
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1758239307</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3107302441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4611-a75734d094897d7c16cd3753960628a4e58ede82063b4bffea80b5a0b57df8433</originalsourceid><addsrcrecordid>eNqN0U1rFDEYB_Agil2rFz-ABLxUYWreX47t0m4XipW2Wm8hk8mwaWeSNZmh7rfvrNv24EE8hED4PX_I8wfgPUaHGCHyxa1CPiSEYPwCzDAnqBJU_HwJZkhpXSHEyB54U8otQkgLyl6DPUKVplKSGUgn0cYhpN7n6mrtXWiDg8sIf4QhJ3gc0pBtLG3KvZ1UhKmFV77zboDfVnZ6dH4cgrNdgSHCSxtine7hdU7jAA8uokt5tYluNRbYb-5CKZ_eglftpP27x3sffD89uZ6fVecXi-X86LxyTGBcWcklZQ3STGnZSIeFa6jkVAskiLLMc-UbrwgStGZ123qrUM3tdGTTKkbpPjjY5a5z-jX6Mpg-FOe7zkafxmKw5IpQTZH8D8qY0JppPNGPf9HbNOY4fcRgxhhnXPBt4OedcjmVkn1r1jn0Nm8MRmbbmNk2Zv40NuEPj5Fj3fvmmT5VNAG8A_eh85t_RJn52fLyKbTazYQy-N_PMzbfGSGnPZqbrwsj5vJY3hBlFvQBAy2vMA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1444545657</pqid></control><display><type>article</type><title>Enantiomer-Specific In Vitro Biotransformation of Select Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss)</title><source>Wiley</source><creator>Connors, Kristin A. ; Du, Bowen ; Fitzsimmons, Patrick N. ; Chambliss, C. Kevin ; Nichols, John W. ; Brooks, Bryan W.</creator><creatorcontrib>Connors, Kristin A. ; Du, Bowen ; Fitzsimmons, Patrick N. ; Chambliss, C. Kevin ; Nichols, John W. ; Brooks, Bryan W.</creatorcontrib><description>ABSTRACT The occurrence of pharmaceuticals in the environment represents a challenge of emerging concern. Many pharmaceuticals are chiral compounds; however, few studies have examined the relative toxicity of pharmaceutical enantiomers to wildlife. Further, our understanding of stereospecific pharmacokinetics remains largely informed by research on humans and a few well‐studied laboratory test animals, and not by studies conducted with environmentally relevant species, including fish. The objective of this study was to investigate whether rainbow trout display stereospecific in vitro metabolism of three common chiral pharmaceuticals. Metabolism by trout liver S9 fractions was evaluated using a substrate depletion approach, which provides an estimate of intrinsic hepatic clearance (CLIN VITRO,INT). No biotransformation was observed for rac‐, R‐, or S‐fluoxetine. Ibuprofen, including both enantiomers and the racemic mixture, appeared to undergo slow metabolism, but the resulting substrate depletion curves did not differ significantly from those of inactive controls. Contrary to relative clearance rates in humans, S(−)‐propranolol was more rapidly cleared than the R(+)‐ enantiomer. This work demonstrates that relative clearance rates and the effects of racemic mixtures in trout could not have been predicted based on human data. Additional research describing species differences and exploring tools for species extrapolation in biomedical and environmental studies is needed. Chirality 25:763–767, 2013, © 2013 Wiley Periodicals, Inc.</description><identifier>ISSN: 0899-0042</identifier><identifier>EISSN: 1520-636X</identifier><identifier>DOI: 10.1002/chir.22211</identifier><identifier>PMID: 23893772</identifier><language>eng</language><publisher>United States: Blackwell Publishing Ltd</publisher><subject>Animals ; bioaccumulation ; Biotransformation ; Clearances ; comparative pharmacokinetics ; contaminants of emerging concern ; Depletion ; Enantiomers ; Environmental Pollutants - chemistry ; Environmental Pollutants - metabolism ; environmental risk assessment ; Human ; In vitro testing ; metabolic biotransformation ; Metabolism ; Oncorhynchus mykiss ; Oncorhynchus mykiss - metabolism ; Pharmaceutical Preparations - chemistry ; Pharmaceutical Preparations - metabolism ; Pharmaceuticals ; Stereoisomerism ; Substrate Specificity ; Trout</subject><ispartof>Chirality (New York, N.Y.), 2013-11, Vol.25 (11), p.763-767</ispartof><rights>2013 Wiley Periodicals, Inc</rights><rights>2013 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4611-a75734d094897d7c16cd3753960628a4e58ede82063b4bffea80b5a0b57df8433</citedby><cites>FETCH-LOGICAL-c4611-a75734d094897d7c16cd3753960628a4e58ede82063b4bffea80b5a0b57df8433</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23893772$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Connors, Kristin A.</creatorcontrib><creatorcontrib>Du, Bowen</creatorcontrib><creatorcontrib>Fitzsimmons, Patrick N.</creatorcontrib><creatorcontrib>Chambliss, C. Kevin</creatorcontrib><creatorcontrib>Nichols, John W.</creatorcontrib><creatorcontrib>Brooks, Bryan W.</creatorcontrib><title>Enantiomer-Specific In Vitro Biotransformation of Select Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss)</title><title>Chirality (New York, N.Y.)</title><addtitle>Chirality</addtitle><description>ABSTRACT The occurrence of pharmaceuticals in the environment represents a challenge of emerging concern. Many pharmaceuticals are chiral compounds; however, few studies have examined the relative toxicity of pharmaceutical enantiomers to wildlife. Further, our understanding of stereospecific pharmacokinetics remains largely informed by research on humans and a few well‐studied laboratory test animals, and not by studies conducted with environmentally relevant species, including fish. The objective of this study was to investigate whether rainbow trout display stereospecific in vitro metabolism of three common chiral pharmaceuticals. Metabolism by trout liver S9 fractions was evaluated using a substrate depletion approach, which provides an estimate of intrinsic hepatic clearance (CLIN VITRO,INT). No biotransformation was observed for rac‐, R‐, or S‐fluoxetine. Ibuprofen, including both enantiomers and the racemic mixture, appeared to undergo slow metabolism, but the resulting substrate depletion curves did not differ significantly from those of inactive controls. Contrary to relative clearance rates in humans, S(−)‐propranolol was more rapidly cleared than the R(+)‐ enantiomer. This work demonstrates that relative clearance rates and the effects of racemic mixtures in trout could not have been predicted based on human data. Additional research describing species differences and exploring tools for species extrapolation in biomedical and environmental studies is needed. Chirality 25:763–767, 2013, © 2013 Wiley Periodicals, Inc.</description><subject>Animals</subject><subject>bioaccumulation</subject><subject>Biotransformation</subject><subject>Clearances</subject><subject>comparative pharmacokinetics</subject><subject>contaminants of emerging concern</subject><subject>Depletion</subject><subject>Enantiomers</subject><subject>Environmental Pollutants - chemistry</subject><subject>Environmental Pollutants - metabolism</subject><subject>environmental risk assessment</subject><subject>Human</subject><subject>In vitro testing</subject><subject>metabolic biotransformation</subject><subject>Metabolism</subject><subject>Oncorhynchus mykiss</subject><subject>Oncorhynchus mykiss - metabolism</subject><subject>Pharmaceutical Preparations - chemistry</subject><subject>Pharmaceutical Preparations - metabolism</subject><subject>Pharmaceuticals</subject><subject>Stereoisomerism</subject><subject>Substrate Specificity</subject><subject>Trout</subject><issn>0899-0042</issn><issn>1520-636X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqN0U1rFDEYB_Agil2rFz-ABLxUYWreX47t0m4XipW2Wm8hk8mwaWeSNZmh7rfvrNv24EE8hED4PX_I8wfgPUaHGCHyxa1CPiSEYPwCzDAnqBJU_HwJZkhpXSHEyB54U8otQkgLyl6DPUKVplKSGUgn0cYhpN7n6mrtXWiDg8sIf4QhJ3gc0pBtLG3KvZ1UhKmFV77zboDfVnZ6dH4cgrNdgSHCSxtine7hdU7jAA8uokt5tYluNRbYb-5CKZ_eglftpP27x3sffD89uZ6fVecXi-X86LxyTGBcWcklZQ3STGnZSIeFa6jkVAskiLLMc-UbrwgStGZ123qrUM3tdGTTKkbpPjjY5a5z-jX6Mpg-FOe7zkafxmKw5IpQTZH8D8qY0JppPNGPf9HbNOY4fcRgxhhnXPBt4OedcjmVkn1r1jn0Nm8MRmbbmNk2Zv40NuEPj5Fj3fvmmT5VNAG8A_eh85t_RJn52fLyKbTazYQy-N_PMzbfGSGnPZqbrwsj5vJY3hBlFvQBAy2vMA</recordid><startdate>201311</startdate><enddate>201311</enddate><creator>Connors, Kristin A.</creator><creator>Du, Bowen</creator><creator>Fitzsimmons, Patrick N.</creator><creator>Chambliss, C. Kevin</creator><creator>Nichols, John W.</creator><creator>Brooks, Bryan W.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7QR</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>JG9</scope><scope>L7M</scope><scope>F1W</scope><scope>H95</scope><scope>L.G</scope></search><sort><creationdate>201311</creationdate><title>Enantiomer-Specific In Vitro Biotransformation of Select Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss)</title><author>Connors, Kristin A. ; Du, Bowen ; Fitzsimmons, Patrick N. ; Chambliss, C. Kevin ; Nichols, John W. ; Brooks, Bryan W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4611-a75734d094897d7c16cd3753960628a4e58ede82063b4bffea80b5a0b57df8433</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>bioaccumulation</topic><topic>Biotransformation</topic><topic>Clearances</topic><topic>comparative pharmacokinetics</topic><topic>contaminants of emerging concern</topic><topic>Depletion</topic><topic>Enantiomers</topic><topic>Environmental Pollutants - chemistry</topic><topic>Environmental Pollutants - metabolism</topic><topic>environmental risk assessment</topic><topic>Human</topic><topic>In vitro testing</topic><topic>metabolic biotransformation</topic><topic>Metabolism</topic><topic>Oncorhynchus mykiss</topic><topic>Oncorhynchus mykiss - metabolism</topic><topic>Pharmaceutical Preparations - chemistry</topic><topic>Pharmaceutical Preparations - metabolism</topic><topic>Pharmaceuticals</topic><topic>Stereoisomerism</topic><topic>Substrate Specificity</topic><topic>Trout</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Connors, Kristin A.</creatorcontrib><creatorcontrib>Du, Bowen</creatorcontrib><creatorcontrib>Fitzsimmons, Patrick N.</creatorcontrib><creatorcontrib>Chambliss, C. Kevin</creatorcontrib><creatorcontrib>Nichols, John W.</creatorcontrib><creatorcontrib>Brooks, Bryan W.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Materials Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) 1: Biological Sciences &amp; Living Resources</collection><collection>Aquatic Science &amp; Fisheries Abstracts (ASFA) Professional</collection><jtitle>Chirality (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Connors, Kristin A.</au><au>Du, Bowen</au><au>Fitzsimmons, Patrick N.</au><au>Chambliss, C. Kevin</au><au>Nichols, John W.</au><au>Brooks, Bryan W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Enantiomer-Specific In Vitro Biotransformation of Select Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss)</atitle><jtitle>Chirality (New York, N.Y.)</jtitle><addtitle>Chirality</addtitle><date>2013-11</date><risdate>2013</risdate><volume>25</volume><issue>11</issue><spage>763</spage><epage>767</epage><pages>763-767</pages><issn>0899-0042</issn><eissn>1520-636X</eissn><abstract>ABSTRACT The occurrence of pharmaceuticals in the environment represents a challenge of emerging concern. Many pharmaceuticals are chiral compounds; however, few studies have examined the relative toxicity of pharmaceutical enantiomers to wildlife. Further, our understanding of stereospecific pharmacokinetics remains largely informed by research on humans and a few well‐studied laboratory test animals, and not by studies conducted with environmentally relevant species, including fish. The objective of this study was to investigate whether rainbow trout display stereospecific in vitro metabolism of three common chiral pharmaceuticals. Metabolism by trout liver S9 fractions was evaluated using a substrate depletion approach, which provides an estimate of intrinsic hepatic clearance (CLIN VITRO,INT). No biotransformation was observed for rac‐, R‐, or S‐fluoxetine. Ibuprofen, including both enantiomers and the racemic mixture, appeared to undergo slow metabolism, but the resulting substrate depletion curves did not differ significantly from those of inactive controls. Contrary to relative clearance rates in humans, S(−)‐propranolol was more rapidly cleared than the R(+)‐ enantiomer. This work demonstrates that relative clearance rates and the effects of racemic mixtures in trout could not have been predicted based on human data. Additional research describing species differences and exploring tools for species extrapolation in biomedical and environmental studies is needed. Chirality 25:763–767, 2013, © 2013 Wiley Periodicals, Inc.</abstract><cop>United States</cop><pub>Blackwell Publishing Ltd</pub><pmid>23893772</pmid><doi>10.1002/chir.22211</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0899-0042
ispartof Chirality (New York, N.Y.), 2013-11, Vol.25 (11), p.763-767
issn 0899-0042
1520-636X
language eng
recordid cdi_proquest_miscellaneous_1758239307
source Wiley
subjects Animals
bioaccumulation
Biotransformation
Clearances
comparative pharmacokinetics
contaminants of emerging concern
Depletion
Enantiomers
Environmental Pollutants - chemistry
Environmental Pollutants - metabolism
environmental risk assessment
Human
In vitro testing
metabolic biotransformation
Metabolism
Oncorhynchus mykiss
Oncorhynchus mykiss - metabolism
Pharmaceutical Preparations - chemistry
Pharmaceutical Preparations - metabolism
Pharmaceuticals
Stereoisomerism
Substrate Specificity
Trout
title Enantiomer-Specific In Vitro Biotransformation of Select Pharmaceuticals in Rainbow Trout (Oncorhynchus mykiss)
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T06%3A32%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Enantiomer-Specific%20In%20Vitro%20Biotransformation%20of%20Select%20Pharmaceuticals%20in%20Rainbow%20Trout%20(Oncorhynchus%20mykiss)&rft.jtitle=Chirality%20(New%20York,%20N.Y.)&rft.au=Connors,%20Kristin%20A.&rft.date=2013-11&rft.volume=25&rft.issue=11&rft.spage=763&rft.epage=767&rft.pages=763-767&rft.issn=0899-0042&rft.eissn=1520-636X&rft_id=info:doi/10.1002/chir.22211&rft_dat=%3Cproquest_cross%3E3107302441%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4611-a75734d094897d7c16cd3753960628a4e58ede82063b4bffea80b5a0b57df8433%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1444545657&rft_id=info:pmid/23893772&rfr_iscdi=true